NCT07157319 Zadek Osteotomy for Treatment of Haglund's Syndrome
| NCT ID | NCT07157319 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Haglund's Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2025-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2025-04-01 with a primary completion date of 2025-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Haglund's syndrome is an abnormality of the bone and soft tissues in the foot. An enlargement of the bony section of the heel (where the Achilles tendon is inserted) triggers this condition. * symptom includes insertional Achilles tendinopathy (IAT), The patient with HS often has a red, irritated, painful heel. And they often complain the enlargement of the posterior heel, which make it more difficult to footwear or sport * Zadek described the Zadek Osteotomy option for the treatment of Haglund's syndrome This operation can change the calcaneus' anatomical length and elevate the distal insertion point of the Achilles tendon \- It is a prospective case series study that will be done in Orthopedics and Traumatology department of Sohag university hospitals on patients suffering from Haglund's syndrome and treated by Zadek osteotomy * This study aims to evaluate short term clinical, radiological and functional outcomes of Zadek osteotomy for treatment of Haglund's syndrome
Eligibility Criteria
Inclusion Criteria: * patients over 18 years of age and less than 60 Yrs * All patients had at least six months of conservative treatment Exclusion Criteria: 1. patients below 18 years of age and more than 60 Yrs 2. patients of Haglund's syndrome with AT rupture or degeneration 3. uncontrolled diabetic patients with or without neuropathic joint destruction, 4. Infection such as osteomyelitis. 5. Charcot joint. 6. Peripheral vascular disease
Contact & Investigator
Mohamed Kamal Abd Alhakeem Mohamed Kamal Abd Alhakeem, Orthopedics resident, Sohag Un
✉ mo.hakeem2020@gmail.com📞 +201550529605
Frequently Asked Questions
Who can join the NCT07157319 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Haglund's Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07157319 currently recruiting?
Yes, NCT07157319 is actively recruiting participants. Contact the research team at mo.hakeem2020@gmail.com for enrollment information.
Where is the NCT07157319 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT07157319 clinical trial?
NCT07157319 is sponsored by Sohag University. The trial plans to enroll 30 participants.